Shinji Nitanda
Director of Finance/CFO at SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
Profile
Shinji Nitanda currently works at Shin Nippon Biomedical Laboratories, Ltd., as Chief Financial Officer & Senior Managing Director from 2019, Medipolis Medical Research Institute, as Managing Director, SNBL China, Ltd., as Member-Supervisory Board, and Satsuma Pharmaceuticals, Inc., as Secretary from 2023.
Shinji Nitanda active positions
| Companies | Position | Start |
|---|---|---|
| SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. | Director of Finance/CFO | 2017-06-28 |
| SATSUMA PHARMACEUTICALS, INC. | Corporate Secretary | 2023-06-07 |
Medipolis Medical Research Institute
 Medipolis Medical Research Institute Medical/Nursing ServicesHealth Services Medipolis Medical Research Institute offers proton beam cancer treatment. The company was founded on March 2006 and is headquartered in Ibusuki, Japan. | Director/Board Member | - |
SNBL China, Ltd.
 SNBL China, Ltd. Agricultural Commodities/MillingProcess Industries Part of Pharmaron Beijing Co., Ltd., SNBL China, Ltd. breeds and sells laboratory animals. The private company is based in Zhaoqing, China. The Chinese company was founded in 2003. The CEO is Yan Wei Liu. SNBL China was acquired by Pharmaron Beijing Co., Ltd. from Shin Nippon Biomedical Laboratories, Ltd. on April 30, 2021. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. | Commercial Services |
| Private companies | 3 |
|---|---|
Medipolis Medical Research Institute
Medipolis Medical Research Institute Medical/Nursing ServicesHealth Services Medipolis Medical Research Institute offers proton beam cancer treatment. The company was founded on March 2006 and is headquartered in Ibusuki, Japan. | Health Services |
SNBL China, Ltd.
SNBL China, Ltd. Agricultural Commodities/MillingProcess Industries Part of Pharmaron Beijing Co., Ltd., SNBL China, Ltd. breeds and sells laboratory animals. The private company is based in Zhaoqing, China. The Chinese company was founded in 2003. The CEO is Yan Wei Liu. SNBL China was acquired by Pharmaron Beijing Co., Ltd. from Shin Nippon Biomedical Laboratories, Ltd. on April 30, 2021. | Process Industries |
Satsuma Pharmaceuticals, Inc.
 Satsuma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraines. Its product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, or DHE, which is designed to be self-administered with a proprietary pre-filled, single-use, nasal delivery device. The company was founded by John Kollins on June 21, 2016 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Shinji Nitanda